speb/financial-data huggingface dataset:
LAL.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 519911000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 519911000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 6986000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 6986000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
LAL.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 86383000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 18169000.00
LAL.NS income_statement (annual, 2026-03-31) — Normalized Income: 43528000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 8726000.00
LAL.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -140004000.00
LAL.NS income_statement (annual, 2026-03-31) — Operating Income: 57621000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Operating Income: 38111000.00
LAL.NS income_statement (annual, 2026-03-31) — Operating Revenue: 727499000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 257598000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 172736551.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 172736551.00
LAL.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 17122000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 17122000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 809000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 809000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 347599000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 347599000.00
LAL.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 9884000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: -1000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: -1000.00
LAL.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 13857000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -23285000.00
LAL.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 100934000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 25465000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 14569000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 14569000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 59534000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 59534000.00
LAL.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAL.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAL.NS balance_sheet (annual, 2026-03-31) — Payables: 110670000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Payables: 110670000.00
LAL.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 978000.00
LAL.NS income_statement (annual, 2026-03-31) — Pretax Income: 60295000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 11110000.00
LAL.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -48074000.00
LAL.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 513394000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 180182000.00
LAL.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 14905000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3344000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Share Issued: 172736551.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 172736551.00
LAL.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 520336000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 520336000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 519911000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 519911000.00
LAL.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LAL.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LAL.NS income_statement (annual, 2026-03-31) — Tax Provision: 16768000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 2384000.00
LAL.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.28
LAL.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
LAL.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -22515000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Assets: 877538000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 877538000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 522738000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 522738000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Debt: 200688000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 200688000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 520336000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 520336000.00
LAL.NS income_statement (annual, 2026-03-31) — Total Expenses: 669878000.00
LAL.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 219487000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 357202000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 357202000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 89533000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 89533000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 33258000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 33258000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 18466000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 18466000.00
LAL.NS balance_sheet (annual, 2026-03-31) — Working Capital: 464061000.00
LAL.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 464061000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — +Operating Expense: 8480000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — +Total Revenue: 20874000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 1473840000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 853950000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -2842150000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 932400000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -284660000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Amortization: 301420000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 104010000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 165371703.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Basic EPS: 20.85
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 2443000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 4043430000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -4761000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 1869150000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 833450000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 3781950000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 6816550000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -1167000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 3572230000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 209720000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -100000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -177000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 160000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Change In Payable: 34000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -182000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -167000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 1339000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Common Stock: 833450000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -1166600000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 15080770000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 2000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 159330000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 5023000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Current Assets: 8751510000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 480560000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Current Debt: 1788530000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 2269090000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 4999880000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 270000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Deferred Tax: 1246000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Depreciation: 1081000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 1081000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 1081000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 1081000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 165888862.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Diluted EPS: 20.79
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 3448000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — EBIT: 5051000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — EBITDA: 6132000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — End Cash Position: 3782000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 1364000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -294000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -31000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 6000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 1310220000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Goodwill: 5499040000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 9604610000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1138610000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 7305510000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Gross Profit: 15851000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Interest Expense: 302000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 302000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Interest Income: 472610000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 472610000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -304000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 496000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Inventory: 525410000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 18535970000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -4492000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 104010000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 2000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 3454000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 269860000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 1388590000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 1666670000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 3055260000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 3454000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: 0.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 2832890000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 354600000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Minority Interests: -55000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -4576000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 2000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Income: 3448000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 3448000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 3503000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 3448000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 3448000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 3503000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 3503000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -3820000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Interest Income: -302000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 4333000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 3454000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 3454000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -302000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Net PPE: 4463360000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -925000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: 0.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 5476160000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 370380000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 40390000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 136370000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 6132000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Normalized Income: 3448000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 4467000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Operating Income: 7371000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Operating Revenue: 20874000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 165523826.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -10000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 184000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 346000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 582860000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 4105570000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -170000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: -148450000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: -2320000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 3750000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Payable: 368460000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Properties: 4154000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 209970000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 3034600000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Other Special Charges: 1050000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Payables: 1873860000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: -17000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 270470000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 1300000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Preferred Stock Issuance: 0.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 331680000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Pretax Income: 4749000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -13000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: -4576000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -3820000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -8476000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -941000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 525410000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 5023000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 1081000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 260560000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 260560000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 13950000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 12089290000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 12809000000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 16000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 367640000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1677860000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Share Issued: 166689754.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Special Income Charges: 5910000.00
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Stock Based Compensation: 323000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 15080770000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 5476160000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Tax Provision: 1246000000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.26
LALPATHLAB.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -1300000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Assets: 23532200000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 16747440000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Debt: 5324350000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 15435370000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Total Expenses: 13503000000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 8096830000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 14780690000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 3096950000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 31560000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 37530000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 37530000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 1165928.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Treasury Stock: 161720000.00
LALPATHLAB.NS balance_sheet (annual, 2022-03-31) — Working Capital: 3751630000.00
LALPATHLAB.NS income_statement (annual, 2022-03-31) — Write Off: -6960000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — +Operating Expense: 9435820000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — +Total Revenue: 20166430000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1561000000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 708240000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3751450000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 944330000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -345320000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Amortization: 604140000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 604140000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 264480000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 165728886.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Basic EPS: 14.41
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3781950000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 4445860000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -445660000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 1828240000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 833680000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2637310000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 8143070000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -1030130000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 2502080000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 135230000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 187350000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 32690000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -9340000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Change In Payable: 92270000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 30900000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 354750000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -1144640000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Common Stock: 833680000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -1030130000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 16662980000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 8720000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 39150000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 7291860000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Current Assets: 9730850000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 528350000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1533370000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 2061720000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 4697530000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 291000000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Deferred Tax: 1027500000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Depreciation: 897790000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1501930000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1501930000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 897790000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 166235884.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Diluted EPS: 14.37
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 2388480000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — EBIT: 3813600000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — EBITDA: 5315530000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — End Cash Position: 2637310000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -2831830000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 4114610000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -64210000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -8070000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 1202420000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Goodwill: 5478410000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 9060310000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1053560000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 7800770000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Gross Profit: 12874570000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Interest Expense: 375330000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 375330000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Interest Income: 331780000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 331780000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -377230000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 306260000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Inventory: 338060000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 19029690000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -2873080000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 0.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 264480000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 8720000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 269830000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 1299890000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 833340000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2133230000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1089790000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3045930000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 332470000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Minority Interests: -22290000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -178190000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 8720000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -3840000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Income: 2388480000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 2388480000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 2410770000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 2388480000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 2388480000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 2410770000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 2410770000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -80510000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Interest Income: -43550000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -2560520000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1089790000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -1089790000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -43550000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -1430000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 4049320000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -360120000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7602670000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 404240000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 29410000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 136650000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 5272760000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Normalized Income: 2358491478.77
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 4560270000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Operating Income: 3438750000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 20166430000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 165881156.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 160000000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 316000000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 582640000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 3581900000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 39190000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 3690000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 300000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2211880000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 176150000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 4010000000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 229540000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 5505760000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Other Special Charges: -15030000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Payables: 1742120000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 26120000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 291350000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 301450000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Pretax Income: 3438270000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 75890000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -178190000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -80510000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -11346970000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -365150000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 338060000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 7291860000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1501930000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 248960000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 248960000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1089790000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 10490000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 13505770000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 8786450000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 5030000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 507800000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1710220000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 166735754.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Special Income Charges: -21440000.00
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 228110000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 16662980000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 7602670000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 12781478.77
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Tax Provision: 1027500000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
LALPATHLAB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1064340000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 23855620000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 17496320000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 4194950000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 16995450000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Total Expenses: 16727680000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 6860170000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 14124770000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2162640000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 4970000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 42770000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 42770000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 854598.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Treasury Stock: 118530000.00
LALPATHLAB.NS balance_sheet (annual, 2023-03-31) — Working Capital: 5033320000.00
LALPATHLAB.NS income_statement (annual, 2023-03-31) — Write Off: 36470000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 9952000000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 22265020000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1865670000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 774020000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -4479420000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1058360000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -314880000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Amortization: 601470000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 601470000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 192500000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 166212880.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Basic EPS: 21.53
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2637310000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 4351510000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -574340000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 1635960000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 834780000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 3609330000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 9425950000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -2011690000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 3360550000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 248780000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -35010000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -21560000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 93780000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Change In Payable: 304670000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -71850000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 357390000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 972020000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 834780000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -2011690000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 18492830000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 34880000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 53710000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7644290000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 11266970000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 605770000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 833340000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1439110000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 4635820000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 379000000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 1431580000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 834500000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1435970000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1435970000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 834500000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 166472506.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 21.49
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 3577350000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — EBIT: 5348100000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — EBITDA: 6784070000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 3609330000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -4138630000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 4779000000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -103970000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 2180000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1222720000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill: 5481850000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 8524950000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1088900000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 7963400000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 14620730000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 293590000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 293590000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Interest Income: 554300000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 554300000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -293590000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 453360000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 373070000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 19326170000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -242690000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 337050000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 192500000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 34880000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 269830000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 1030190000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 0.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1030190000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1533370000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 3288350000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 360810000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Minority Interests: -45580000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -3540000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 34880000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -1960000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Income: 3577350000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 3577350000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3622930000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 3577350000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 3577350000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 3622930000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3622930000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -62670000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: 260710000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -147050000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -1533370000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -1533370000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 260710000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 20120000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3483980000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -502910000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 9967880000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 448590000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 23920000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 16060000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 124120000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 6680170000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Normalized Income: 3502877414.72
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 5353340000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Operating Income: 4668730000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 22265020000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 166426154.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 196000000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 348000000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 511500000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 3043100000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -290120000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 7030000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 21170000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2043830000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 149490000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 3430000000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 327500000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 5816620000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Other Special Charges: -7110000.00